NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Receivables (2020 - 2022)

Updated

NovaBridge Biosciences' Receivables came in at $1.18 million for Q4 2022, down 97.4% from $45.02 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Receivables (2020 - 2022) Analysis & Trends

At the end of FY2021, NovaBridge Biosciences' Receivables was $45.02 million, down 17.9% from FY2020.

  • Going back by year, Receivables was $54.85 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.99 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 13.51 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 16.16 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.19 Bn
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.18 Mn
Jun 30, 2022 43.53 Mn
Dec 31, 2021 45.02 Mn
Dec 31, 2020 54.87 Mn
API Access

NovaBridge Biosciences Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NBP&period=max&api_key=YOUR_API_KEY